April 2021
From the NewsToward a reliable oral treatment for sickle cell disease
For those who have sickle cell disease, there are only a few treatment options, which ...
Dose Smarter
Deliver AI-powered personalized dosing recommendations for your patients.
Why Personalized Dosing?
Unlike conventional dosing approaches which assume each patient is an average drug responder, the Dosis platform leverages artificial intelligence and control algorithms to determine a patient’s unique response to a medication and deliver optimal dose recommendations.
Increase Dose Efficiency
Use less drug to achieve equivalent or improved patient outcomes. An increase in dose efficiency means lowered drug exposure for patients and lowered costs for clinics.
Decrease Risk of Adverse Events
Decrease the likelihood of serious adverse events by decreasing patient exposure to drugs. Higher doses are associated with a higher likelihood of adverse events.
The Dosis Platform
Dosis is a cloud-based clinical decision support platform that uses artificial intelligence and control algorithms to personalize drug dosing.
Precise Recommendations
Generates personalized recommendations to keep patients within a specified therapeutic range
Increased Dose Efficiency
Empowers clinicians to use dramatically less medication to achieve the same or better patient outcomes
Proven Track Record
Used in clinics across the United States, and backed by years of peer-reviewed research
Strategic Anemia Advisor
Used in over 15 million treatments, SAA personalizes drug dosing for erythropoiesis-stimulating agents (ESAs), a class of drugs used to treat dialysis patients with chronic anemia.
Our Clinics See Results
Clinics that use SAA achieve equivalent or improved hemoglobin outcomes while using dramatically less drug, resulting in reduced patient drug exposure and reduced drug cost.
Pricing
We earn when you save. Our pricing model is built on aligned incentives, and we only charge a portion of the savings you realize.
Recent News
March 2021
From the NewsRoxadustat Noninferior to Darbepoetin Alfa in Dialysis Patients with Anemia
Anemia, a complication of chronic kidney disease (CKD), results from a decreased synthesis of erythropoietin ...
March 2021
From the NewsRoxadustat Improved Iron Homeostasis in Patients with NDD-CKD
Kidney Week 2020 The causes of anemia in patients with chronic kidney disease are multifactorial, ...